chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 0.48
Sex: M
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: Intussusception, Surgery, Ultrasound abdomen abnormal
Clinical narrative: Pt developed intussusception and had surgery on 4/11/12. Pt still hospitalized currently.
Age: 10.0
Sex: M
Vaccine: HPV4, MNQ, TDAP, VARCEL, HPV4, MNQ, TDAP, VARCEL
Symptoms: Erythema, Skin warm, Swelling
Clinical narrative: Redness/swelling and warm to the touch 1 day after vaccine.
Age: 59.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site pruritus, Joint swelling, Oedema peripheral, Pruritus
Clinical narrative: Onset of itching left arm at site of injection w/ feet swelling and itching and progressed to hands, wrist and palm of hand/fingers and head and rt arm - not on truck accompanied w/ headache and tiredness.
Age: 7.0
Sex: F
Vaccine: RAB
Symptoms: Pyrexia
Clinical narrative: Fevers ranging from 100F to 104.9 F per mother.  Relieved by Tylenol.
Age: 12.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Abdominal discomfort, Asthenia, Body temperature increased, Dizziness, Headache
Clinical narrative: Bleeding at site, headache, dizzy, upset stomach, temp 99-100.  Headache and low energy level for appx 2 weeks.
Age: 12.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Injection site haemorrhage
Clinical narrative: Bleeding at site, headache, dizzy, upset stomach, temp 99-100.  Headache and low energy level for appx 2 weeks.
Age: 4.0
Sex: M
Vaccine: DTAP
Symptoms: Gait disturbance, Injection site erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: By morning of 4/17 injection area was hugely swollen, hard, hot to touch. He had trouble walking. Complained of pain. 4/18 injection area is still large hard and hot but is now also raised and red.
Age: 4.0
Sex: M
Vaccine: DTAP
Symptoms: Pain
Clinical narrative: By morning of 4/17 injection area was hugely swollen, hard, hot to touch. He had trouble walking. Complained of pain. 4/18 injection area is still large hard and hot but is now also raised and red.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Mass
Clinical narrative: Zostavax administered subcutaneously to Left arm on 4/12/12.  The patient states the area is tender to the touch and there is a reddened area of approximately the size of a half-dollar at the site of administration. The patient also states there is an obtuse-shaped lump under the injection site. The patient states she has not had a fever. The information about this reaction was reported to our pharmacy on 4/16/12.
Age: 24.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site pain, Neck pain, Pain in jaw
Clinical narrative: Pt called on 4/6/12. Patient complains of neck & jaw pain, left upper arm pain. Denies any swelling to mouth or jaw. Referred to medical care - pt did not seek medical care. Symptoms resolved by 4/9/12. Follow-up telephone call - denies any symptoms at present.
Age: 61.0
Sex: F
Vaccine: TYP
Symptoms: Asthenia, Decreased appetite, Headache
Clinical narrative: I got a headache on the right side of my head from front to back.  On 04/07/2012 I was too weak to get out of the chair or bed and still had the headache.  On 04/08/2012 I was still weak and still had the headache but the weakness was not as bad as the previous day.  I had no appetite on 04/07/2012.
Age: 24.0
Sex: F
Vaccine: HPV4
Symptoms: VIIth nerve paralysis
Clinical narrative: Information has been received from a physician concerning a 24 year old female patient with no drug reactions/allergies and no pertinent medical history who on 26-JAN-2012 was vaccinated IM with a dose of GARDASIL (lot # 670049/1171AA, expire on 25-FEB-2013). There was no concomitant medication. On 27-MAR-2012, the patient began to have facial palsy. The physician gave her prednisone for the event. No lab diagnostics studies were performed. The patient came to physician's office to seek medical attention. At the time of reporting, the patient was recovering. Upon internal review, facial palsy was determined to be an other important medical event. Additional information has been requested.
Age: 71.0
Sex: M
Vaccine: PPV, TD
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: Swelling & pain in right arm around injection site (PNEUMOVAX).
Age: 17.0
Sex: M
Vaccine: HPV4, MNQ, HPV4, MNQ
Symptoms: Appendicectomy, Appendicitis
Clinical narrative: Appendicitis developed the morning after vaccination requiring appendectomy.
Age: 17.0
Sex: M
Vaccine: HPV4, MNQ, HPV4, MNQ
Symptoms: Abdominal pain lower, Amylase increased, Appendicectomy, Appendicitis, Aspartate aminotransferase increased
Clinical narrative: Appendicitis developed the morning after vaccination requiring appendectomy.
Age: 17.0
Sex: M
Vaccine: HPV4, MNQ, HPV4, MNQ
Symptoms: Blood bilirubin increased, Diarrhoea, Headache, Laparoscopic surgery, Lymphocyte percentage decreased
Clinical narrative: Appendicitis developed the morning after vaccination requiring appendectomy.
Age: 17.0
Sex: M
Vaccine: HPV4, MNQ, HPV4, MNQ
Symptoms: Nausea, Neutrophil percentage increased, Protein total increased, Retching, Ultrasound abdomen abnormal
Clinical narrative: Appendicitis developed the morning after vaccination requiring appendectomy.
Age: 17.0
Sex: M
Vaccine: HPV4, MNQ, HPV4, MNQ
Symptoms: Urine ketone body present, White blood cell count normal, White blood cells urine positive
Clinical narrative: Appendicitis developed the morning after vaccination requiring appendectomy.
Age: 25.0
Sex: F
Vaccine: TDAP, YF
Symptoms: Chest discomfort, Flushing, Swelling face
Clinical narrative: About 1 hr after receiving vaccine got flushing, facial swelling and tightness of chest. Gave IM BENADRYL 50mg x 1 dose. Resolved in about 1/2 hr.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect route of drug administration
Clinical narrative: I am a staff pharmacist at a retail pharmacy. Recently when cleaning up consultation room where we administer vaccines, I noticed supplies had been left on counter from a previous ZOSTAVAX appointment. The ZOSTAVAX vaccine had been given by a colleague earlier that day. I noticed the syringe wrapper that was left out was for a 1 inch syringe. We usually use 1 inch for IM vaccines and 5/8 inch for SC vaccines. I checked the patient documentation form, and noted my colleague had documented that she's given that dose in the deltoid. Next day, I asked my colleague and she said yes she'd given the ZOSTAVAX IM, I advised her that SC is the correct route of administration for ZOSTAVAX. She thought it could be given either way, she tried to find information/research to support that belief, but could not. ZOSTAVAX should be administered subcutaneously as a single dose. The vaccine should not be injection intramuscularly. However, it is not necessary to repeat vaccination if the shingles vaccine is administered intramuscularly. My colleague said of the error: "If your ok with it, then I'm ok with it", and no further discussion or documentation of error took place. I felt like the error should've been reported to our supervisor and our authorizing prescriber and documented per our quality assurance program that we use for dispensing near missed and/or errors. Our written protocol should also be reviewed with clear instructions on what to do in case of error. I reviewed all our patient vaccine documentation forms for ZOSTAVAX and was able to find 8 more times previously (over a 2 year period) where the same colleague documented that she gave the shingles vaccine IM/deltoid. Obviously, I think she will give correctly from now on. But these errors highlight, in my opinion, for the need for ongoing training for vaccine administration. As a pharmacist, I am able to take a very detailed educational program once and be certified to administer vaccines. I am required in my state to keep records for healthcare providers (CPR and AED) and Bloodborne Pathogen training up to date. Which required annual or biannual renewal/review. But I am not required to take additional CE credit in vaccine topics. I took approved class/training in 2009 and the colleague took approved training in 2001.
Age: 1.01
Sex: F
Vaccine: HIBV, MMR, PNC13, VARCEL
Symptoms: Injection site reaction, Rash papular
Clinical narrative: Erythematous papular rash (L) upper thigh improving w/ cool compresses. No systemic illness or involvement.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Injection site rash, Pyrexia, Swelling
Clinical narrative: Rash at site of injection, slight swelling and some fever.
Age: 53.0
Sex: M
Vaccine: DTAP
Symptoms: Diarrhoea, Nausea, Pyrexia
Clinical narrative: Began to feel nauseated, feverish, diarrhea began until 04/18/12, fever broke 04/14/2012.
Age: 25.0
Sex: F
Vaccine: HPV4, TD, HPV4, TD
Symptoms: Arthralgia, Discomfort, Lethargy, Lymphadenopathy, Malaise
Clinical narrative: The day of the vaccine I experienced swollen lymph nodes under the left underarm. I developed a cold, and began to become lethargic and sick for one week. Since then, I've been experiencing chronic joint and muscle aches in my arms, shoulders, hands, lower back, neck, legs and feet. I've tried icing these areas and taking joint supplements, but the pain and discomfort will not abate. I've never experienced this chronic pain until after I began to take the Gardasil vaccine.
Age: 25.0
Sex: F
Vaccine: HPV4, TD, HPV4, TD
Symptoms: Myalgia, Nasopharyngitis
Clinical narrative: The day of the vaccine I experienced swollen lymph nodes under the left underarm. I developed a cold, and began to become lethargic and sick for one week. Since then, I've been experiencing chronic joint and muscle aches in my arms, shoulders, hands, lower back, neck, legs and feet. I've tried icing these areas and taking joint supplements, but the pain and discomfort will not abate. I've never experienced this chronic pain until after I began to take the Gardasil vaccine.
Age: 25.0
Sex: F
Vaccine: HPV4, TD, HPV4, TD
Symptoms: Myalgia, Nasopharyngitis, Pain
Clinical narrative: The day of the vaccine I experienced swollen lymph nodes under the left underarm. I developed a cold, and began to become lethargic and sick for one week. Since then, I've been experiencing chronic joint and muscle aches in my arms, shoulders, hands, lower back, neck, legs and feet. I've tried icing these areas and taking joint supplements, but the pain and discomfort will not abate. I've never experienced this chronic pain until after I began to take the Gardasil vaccine.
Age: 28.0
Sex: F
Vaccine: HEP
Symptoms: Pain in extremity, Sensation of heaviness
Clinical narrative: Pain, heavy feeling to deltoid, some radiation down to hand. No redness, swelling, fever.
Age: 17.0
Sex: M
Vaccine: TYP
Symptoms: Hypoaesthesia, Inappropriate schedule of drug administration, Pruritus, Rash erythematous
Clinical narrative: SMALL RED BUMPS ON BODY, MILD ITCHING, HANDS FEEL NUMB AND ITCHY. STARTED DAY AFTER THE 3RD DOSE OF THE ORAL TYPHOID VACCINE.  PT HAD TAKEN 1 ADDITIONAL DOSE WEEK BEFORE BUT RESTARTED SERIES BECAUSE HE FORGOT THE NEXT DOSE FOR MORE THAN 2 DAYS. HE DID NOT TAKE THE 4TH DOSE WHICH WAS DUE ON 4/16/2012 PER PHYSICIAN RECOMMENDATION.  TOOK BENADRYL FOR ITCHING WITH RESOLUTION OF ITCHING BY FOLLOWING DAY.
Age: 17.0
Sex: M
Vaccine: HPV4, HPV4
Symptoms: Electroencephalogram abnormal, Grand mal convulsion
Clinical narrative: PATIENT HAD A TONIC CLONIC SEIZURE. HE WAS HOSPITALIZED AND FOUND TO HAVE AN ABNORMAL EEG. HE IS NOW ON ANTI-SEIZURE MEDICATION.
Age: 17.0
Sex: M
Vaccine: HPV4, HPV4
Symptoms: Cardiomegaly, Chest X-ray abnormal, Confusional state, Electrocardiogram QT prolonged, Electroencephalogram abnormal
Clinical narrative: PATIENT HAD A TONIC CLONIC SEIZURE. HE WAS HOSPITALIZED AND FOUND TO HAVE AN ABNORMAL EEG. HE IS NOW ON ANTI-SEIZURE MEDICATION.
Age: 17.0
Sex: M
Vaccine: HPV4, HPV4
Symptoms: Fall, Gaze palsy, Grand mal convulsion, Lymphocyte percentage increased, Neutrophil percentage decreased
Clinical narrative: PATIENT HAD A TONIC CLONIC SEIZURE. HE WAS HOSPITALIZED AND FOUND TO HAVE AN ABNORMAL EEG. HE IS NOW ON ANTI-SEIZURE MEDICATION.
Age: 17.0
Sex: M
Vaccine: HPV4, HPV4
Symptoms: Nuclear magnetic resonance imaging brain normal, Postictal state, Unresponsive to stimuli, Ventricular hypertrophy, White blood cell count decreased
Clinical narrative: PATIENT HAD A TONIC CLONIC SEIZURE. HE WAS HOSPITALIZED AND FOUND TO HAVE AN ABNORMAL EEG. HE IS NOW ON ANTI-SEIZURE MEDICATION.
Age: 1.54
Sex: F
Vaccine: DTAP, HEPA
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: The day after the DTaP shot was given my daughter's left upper thigh, around the area of the shot, was swollen, red, and hot to touch. The swelling and redness was 4 inches by 3 inches.  Then on 4/13/2012 her entire left thigh was swollen.
Age: 24.0
Sex: M
Vaccine: ANTH, SMALL, TDAP, TYP
Symptoms: Chest pain, Laboratory test, X-ray
Clinical narrative: Noticed chest pain couple days after during the day randomly feels chest pain since then. Patient came to clinic for follow up on 04/18/2012 and was evaluated by Dr.
Age: 0.18
Sex: F
Vaccine: DTAP
Symptoms: Bradycardia
Clinical narrative: After two weeks of no events on the monitor patient had a serious bradycardia event.
Age: 52.0
Sex: F
Vaccine: VARZOS
Symptoms: Feeling hot, Injection site erythema, Injection site induration, Injection site pain, Injection site pruritus
Clinical narrative: Red itchy hard patch around needle site, today is 18/April it is now bigger and has blisters will go to Doctor tomorrow, it hurts and burns also. Feel hot and icky!!
Age: 52.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site vesicles, Malaise
Clinical narrative: Red itchy hard patch around needle site, today is 18/April it is now bigger and has blisters will go to Doctor tomorrow, it hurts and burns also. Feel hot and icky!!
Age: 0.18
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV1
Symptoms: Petechiae
Clinical narrative: Petechiae on upper chest.
Age: 66.0
Sex: F
Vaccine: PPV, VARZOS
Symptoms: Injection site erythema, Pain, Pyrexia, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Patient states she began feeling feverish, achy about 6 hours after administration. Vaccine site is red, swollen and hot to touch.
Age: 38.0
Sex: F
Vaccine: FLU3
Symptoms: Dyspnoea, Electromyogram, Fatigue, Hypoaesthesia, Lumbar puncture
Clinical narrative: Malaise, fatigue, muscle weakness, shortness of breath upon movement, numbness in hands and feet.
Age: 38.0
Sex: F
Vaccine: FLU3
Symptoms: Malaise, Muscular weakness, Nerve conduction studies, Nuclear magnetic resonance imaging, Oropharyngeal pain
Clinical narrative: Malaise, fatigue, muscle weakness, shortness of breath upon movement, numbness in hands and feet.
Age: 38.0
Sex: F
Vaccine: FLU3
Symptoms: Rhinorrhoea, Scan with contrast
Clinical narrative: Malaise, fatigue, muscle weakness, shortness of breath upon movement, numbness in hands and feet.
Age: 14.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Blood test, Dizziness, Electroencephalogram normal, Headache, Muscle spasms
Clinical narrative: Dizziness, headaches, muscle spasm (seizure like), blurred vision. Two doctor visits, two ER visits. EEG done (4/18/12) but negative results.
Age: 14.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Seizure like phenomena, Vision blurred
Clinical narrative: Dizziness, headaches, muscle spasm (seizure like), blurred vision. Two doctor visits, two ER visits. EEG done (4/18/12) but negative results.
Age: 55.0
Sex: F
Vaccine: PPV, PPV
Symptoms: Dizziness, Dyspnoea, Injection site erythema, Injection site pain, Injection site pruritus
Clinical narrative: Swelling tenderness at site with redness that expanded from lemon sized to 10cm by 12cm on left upper arm. Awoke to day with some transient dizziness and hard time taking deep breath that lasted for a few minutes then resolved. She denies fever chills shortness of breath cough or chest pains or palpitations. Taken Benadryl beginning 4/17/2012 and once this morning befor visit. Repoted helpful with itching and swelling at site but site enlarged despite intervention and cool compressed.
Age: 55.0
Sex: F
Vaccine: PPV, PPV
Symptoms: Injection site swelling
Clinical narrative: Swelling tenderness at site with redness that expanded from lemon sized to 10cm by 12cm on left upper arm. Awoke to day with some transient dizziness and hard time taking deep breath that lasted for a few minutes then resolved. She denies fever chills shortness of breath cough or chest pains or palpitations. Taken Benadryl beginning 4/17/2012 and once this morning befor visit. Repoted helpful with itching and swelling at site but site enlarged despite intervention and cool compressed.
Age: 55.0
Sex: F
Vaccine: PPV, PPV
Symptoms: Dyspnoea, Injection site erythema, Injection site reaction
Clinical narrative: Swelling tenderness at site with redness that expanded from lemon sized to 10cm by 12cm on left upper arm. Awoke to day with some transient dizziness and hard time taking deep breath that lasted for a few minutes then resolved. She denies fever chills shortness of breath cough or chest pains or palpitations. Taken Benadryl beginning 4/17/2012 and once this morning befor visit. Repoted helpful with itching and swelling at site but site enlarged despite intervention and cool compressed.
Age: 25.0
Sex: M
Vaccine: MNQ
Symptoms: Arthralgia, Dizziness, Lymphadenopathy, Nausea, Pyrexia
Clinical narrative: Dizziness, Joint pain, Swollen lymph nodes, Nausea, Vomiting, Fever of 101F.
Age: 25.0
Sex: M
Vaccine: MNQ
Symptoms: Vomiting
Clinical narrative: Dizziness, Joint pain, Swollen lymph nodes, Nausea, Vomiting, Fever of 101F.
Age: 1.28
Sex: M
Vaccine: DTAP, HIBV, PNC13
Symptoms: Injection site erythema, Injection site rash, Injection site reaction, Pyrexia, Skin plaque
Clinical narrative: Rash, red, plaque-like at injection site on left thigh approx. 4-5 cm in diameter. Red, rash, plaque-like at injection site on right thigh approx. 1-2cm in diameter. Fever.
Age: 62.0
Sex: F
Vaccine: HEPAB
Symptoms: Injection site pain, Limb discomfort, Pain in extremity
Clinical narrative: Complained of pain when shot given. Continues to have pain in arm with pressure such that unable to sleep on side shot given. Some relief with some arthritis ointment. No redness or lumps at site of injection.
Age: 59.0
Sex: F
Vaccine: TDAP
Symptoms: Arthralgia, Chills, Cold sweat, Heart rate increased, Injection site erythema
Clinical narrative: 102 degree fever -> 99.1 degrees 3 days. Inj. site red, hard lump, swollen (3 inch area). Overall body-joint aches 4 days. Swollen lymph nodes. Fast pulse, clammy-chills.
Age: 59.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site induration, Injection site swelling, Lymphadenopathy, Pyrexia
Clinical narrative: 102 degree fever -> 99.1 degrees 3 days. Inj. site red, hard lump, swollen (3 inch area). Overall body-joint aches 4 days. Swollen lymph nodes. Fast pulse, clammy-chills.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Erythema, Inflammation
Clinical narrative: The area was mildly red and inflamed.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Dizziness, Syncope
Clinical narrative: ZOSTAVAX vaccine was administer 2:30 pm. Pt fainted 10 minutes later. 911 was called and pt was driven to hospital b/c pt was complaining of dizziness.
Age: 11.0
Sex: F
Vaccine: HPV4, HPV4, HPV4
Symptoms: Anaphylactic reaction, Dyspnoea, Lip oedema, Rash, Tongue oedema
Clinical narrative: Information has been received from a physician concerning a 11 year old female patient with no adverse reaction reported after first dose of GARDASIL, (date of vaccination, dose, route and lot# not reported) who on an unknown date was vaccinated with a second 0.5 ml dose of GARDASIL, (route and lot# not reported). Subsequently, on an unknown date (reported as about 3 hours after the patient left the physician office) the patient experienced anaphylactic reaction with tongue swelling. The patient was brought to an unspecified ER, but it was unknown if the patient was admitted. The patient received intravenously: BENADRYL and steroids (unspecified). Therapy with GARDASIL was discontinued on an unknown date (it was reported that the series was discontinued after that adverse event and the patient would not be getting her third dose). Adverse event improved. At the time of the report the patient's status was recovered (recovery date was not reported). Upon internal review anaphylactic reaction treated with IV BENADRYL and IV steroids (unspecified) was determined to be an other important medical event. Follow up information has been received from a registered nurse concerning a 11 year old female patient with no adverse reaction reported after first dose of GARDASIL, received on 19-JUL-2011, (dose, route not reported), Lot# 668670/0476AA who at 15:30 on 16-JAN-2012, was vaccinated with a second 0.5 ml dose of GARDASIL, (route not reported), Lot# 671006/1291AA. The patient did not receive any concomitant vaccinations at the time. Three hours after receiving a second dose of GARDASIL, on16-JAN-2012, the patient experiencing lip swelling, tongue swelling, itching and shortness of breath. The patient was taken to hospital and treated with epinephrine, BENADRYL, IV and steroids (unspecified). The patient was not admitted to the hospital. The outcome was not reported. Upon internal review, lip swelling, tongue swelling, itching and shortness of breath were considered to be other important medical events. Additional information has been requested.
Age: 11.0
Sex: F
Vaccine: HPV4, HPV4, HPV4
Symptoms: Anaphylactic reaction, Anxiety, Dysphonia, Dyspnoea, Lip oedema
Clinical narrative: Information has been received from a physician concerning a 11 year old female patient with no adverse reaction reported after first dose of GARDASIL, (date of vaccination, dose, route and lot# not reported) who on an unknown date was vaccinated with a second 0.5 ml dose of GARDASIL, (route and lot# not reported). Subsequently, on an unknown date (reported as about 3 hours after the patient left the physician office) the patient experienced anaphylactic reaction with tongue swelling. The patient was brought to an unspecified ER, but it was unknown if the patient was admitted. The patient received intravenously: BENADRYL and steroids (unspecified). Therapy with GARDASIL was discontinued on an unknown date (it was reported that the series was discontinued after that adverse event and the patient would not be getting her third dose). Adverse event improved. At the time of the report the patient's status was recovered (recovery date was not reported). Upon internal review anaphylactic reaction treated with IV BENADRYL and IV steroids (unspecified) was determined to be an other important medical event. Follow up information has been received from a registered nurse concerning a 11 year old female patient with no adverse reaction reported after first dose of GARDASIL, received on 19-JUL-2011, (dose, route not reported), Lot# 668670/0476AA who at 15:30 on 16-JAN-2012, was vaccinated with a second 0.5 ml dose of GARDASIL, (route not reported), Lot# 671006/1291AA. The patient did not receive any concomitant vaccinations at the time. Three hours after receiving a second dose of GARDASIL, on16-JAN-2012, the patient experiencing lip swelling, tongue swelling, itching and shortness of breath. The patient was taken to hospital and treated with epinephrine, BENADRYL, IV and steroids (unspecified). The patient was not admitted to the hospital. The outcome was not reported. Upon internal review, lip swelling, tongue swelling, itching and shortness of breath were considered to be other important medical events. Additional information has been requested.
Age: 11.0
Sex: F
Vaccine: HPV4, HPV4, HPV4
Symptoms: Lip swelling, Pruritus, Rash, Sensation of foreign body, Swollen tongue
Clinical narrative: Information has been received from a physician concerning a 11 year old female patient with no adverse reaction reported after first dose of GARDASIL, (date of vaccination, dose, route and lot# not reported) who on an unknown date was vaccinated with a second 0.5 ml dose of GARDASIL, (route and lot# not reported). Subsequently, on an unknown date (reported as about 3 hours after the patient left the physician office) the patient experienced anaphylactic reaction with tongue swelling. The patient was brought to an unspecified ER, but it was unknown if the patient was admitted. The patient received intravenously: BENADRYL and steroids (unspecified). Therapy with GARDASIL was discontinued on an unknown date (it was reported that the series was discontinued after that adverse event and the patient would not be getting her third dose). Adverse event improved. At the time of the report the patient's status was recovered (recovery date was not reported). Upon internal review anaphylactic reaction treated with IV BENADRYL and IV steroids (unspecified) was determined to be an other important medical event. Follow up information has been received from a registered nurse concerning a 11 year old female patient with no adverse reaction reported after first dose of GARDASIL, received on 19-JUL-2011, (dose, route not reported), Lot# 668670/0476AA who at 15:30 on 16-JAN-2012, was vaccinated with a second 0.5 ml dose of GARDASIL, (route not reported), Lot# 671006/1291AA. The patient did not receive any concomitant vaccinations at the time. Three hours after receiving a second dose of GARDASIL, on16-JAN-2012, the patient experiencing lip swelling, tongue swelling, itching and shortness of breath. The patient was taken to hospital and treated with epinephrine, BENADRYL, IV and steroids (unspecified). The patient was not admitted to the hospital. The outcome was not reported. Upon internal review, lip swelling, tongue swelling, itching and shortness of breath were considered to be other important medical events. Additional information has been requested.
Age: 11.0
Sex: F
Vaccine: HPV4, HPV4, HPV4
Symptoms: Tongue oedema, Urticaria, X-ray
Clinical narrative: Information has been received from a physician concerning a 11 year old female patient with no adverse reaction reported after first dose of GARDASIL, (date of vaccination, dose, route and lot# not reported) who on an unknown date was vaccinated with a second 0.5 ml dose of GARDASIL, (route and lot# not reported). Subsequently, on an unknown date (reported as about 3 hours after the patient left the physician office) the patient experienced anaphylactic reaction with tongue swelling. The patient was brought to an unspecified ER, but it was unknown if the patient was admitted. The patient received intravenously: BENADRYL and steroids (unspecified). Therapy with GARDASIL was discontinued on an unknown date (it was reported that the series was discontinued after that adverse event and the patient would not be getting her third dose). Adverse event improved. At the time of the report the patient's status was recovered (recovery date was not reported). Upon internal review anaphylactic reaction treated with IV BENADRYL and IV steroids (unspecified) was determined to be an other important medical event. Follow up information has been received from a registered nurse concerning a 11 year old female patient with no adverse reaction reported after first dose of GARDASIL, received on 19-JUL-2011, (dose, route not reported), Lot# 668670/0476AA who at 15:30 on 16-JAN-2012, was vaccinated with a second 0.5 ml dose of GARDASIL, (route not reported), Lot# 671006/1291AA. The patient did not receive any concomitant vaccinations at the time. Three hours after receiving a second dose of GARDASIL, on16-JAN-2012, the patient experiencing lip swelling, tongue swelling, itching and shortness of breath. The patient was taken to hospital and treated with epinephrine, BENADRYL, IV and steroids (unspecified). The patient was not admitted to the hospital. The outcome was not reported. Upon internal review, lip swelling, tongue swelling, itching and shortness of breath were considered to be other important medical events. Additional information has been requested.
Age: 11.0
Sex: F
Vaccine: HPV4, HPV4, HPV4
Symptoms: Anaphylactic reaction, Dyspnoea, Lip swelling, Pruritus, Swollen tongue
Clinical narrative: Information has been received from a physician concerning a 11 year old female patient with no adverse reaction reported after first dose of GARDASIL, (date of vaccination, dose, route and lot# not reported) who on an unknown date was vaccinated with a second 0.5 ml dose of GARDASIL, (route and lot# not reported). Subsequently, on an unknown date (reported as about 3 hours after the patient left the physician office) the patient experienced anaphylactic reaction with tongue swelling. The patient was brought to an unspecified ER, but it was unknown if the patient was admitted. The patient received intravenously: BENADRYL and steroids (unspecified). Therapy with GARDASIL was discontinued on an unknown date (it was reported that the series was discontinued after that adverse event and the patient would not be getting her third dose). Adverse event improved. At the time of the report the patient's status was recovered (recovery date was not reported). Upon internal review anaphylactic reaction treated with IV BENADRYL and IV steroids (unspecified) was determined to be an other important medical event. Follow up information has been received from a registered nurse concerning a 11 year old female patient with no adverse reaction reported after first dose of GARDASIL, received on 19-JUL-2011, (dose, route not reported), Lot# 668670/0476AA who at 15:30 on 16-JAN-2012, was vaccinated with a second 0.5 ml dose of GARDASIL, (route not reported), Lot# 671006/1291AA. The patient did not receive any concomitant vaccinations at the time. Three hours after receiving a second dose of GARDASIL, on16-JAN-2012, the patient experiencing lip swelling, tongue swelling, itching and shortness of breath. The patient was taken to hospital and treated with epinephrine, BENADRYL, IV and steroids (unspecified). The patient was not admitted to the hospital. The outcome was not reported. Upon internal review, lip swelling, tongue swelling, itching and shortness of breath were considered to be other important medical events. Additional information has been requested.
Age: 15.0
Sex: M
Vaccine: HPV4, HPV4, HPV4
Symptoms: Blood glucose normal, Hypotension, Seizure like phenomena
Clinical narrative: Patient showed signs of seizure tonic clonic for less than 3 seconds, paleness, hypotension and dizziness. Persisted for about 20 min. He had no recollection of seizing event.
Age: 15.0
Sex: M
Vaccine: HPV4, HPV4, HPV4
Symptoms: Dizziness, Grand mal convulsion, Hypotension, Pallor
Clinical narrative: Patient showed signs of seizure tonic clonic for less than 3 seconds, paleness, hypotension and dizziness. Persisted for about 20 min. He had no recollection of seizing event.
Age: 39.0
Sex: F
Vaccine: ANTH, ANTH
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Itchy rash on upper arm underneath injection site.
Age: 39.0
Sex: F
Vaccine: ANTH, ANTH
Symptoms: Rash pruritic
Clinical narrative: Itchy rash on upper arm underneath injection site.
Age: 64.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Autoimmune disorder, Cough, Influenza like illness, Oedema peripheral, Renal disorder
Clinical narrative: Case number PHEH2012US008057 is an initial spontaneous report received from a consumer on 12 Apr 2012: This case refers to a 64-year-old male patient. He was vaccinated with FLUVIRIN (batch number: 1100801) in the left deltoid intramuscularly on 10 Oct 2011. Approximately 3-4 weeks after vaccination, he went to another state. The following morning he woke up with swelling in his calves, ankles and feet bilaterally with the left being more swollen then the right. These symptoms lasted for more than 30-days. He reported that "the swelling now seems to be gone of a morning but returns during the day". He consulted a nephrologist sometime in Jan 2012. He underwent kidney biopsy which completed 3 weeks ago (no dates provided). Biopsy showed some type of damage to his kidney. He was not hospitalized. Edema was continued. He had follow-up appointment with his physician on 12 Apr 2012. The final outcome of the events was reported as unknown.
Age: 64.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Biopsy kidney abnormal, Joint swelling, Oedema, Oedema peripheral, Renal disorder
Clinical narrative: Case number PHEH2012US008057 is an initial spontaneous report received from a consumer on 12 Apr 2012: This case refers to a 64-year-old male patient. He was vaccinated with FLUVIRIN (batch number: 1100801) in the left deltoid intramuscularly on 10 Oct 2011. Approximately 3-4 weeks after vaccination, he went to another state. The following morning he woke up with swelling in his calves, ankles and feet bilaterally with the left being more swollen then the right. These symptoms lasted for more than 30-days. He reported that "the swelling now seems to be gone of a morning but returns during the day". He consulted a nephrologist sometime in Jan 2012. He underwent kidney biopsy which completed 3 weeks ago (no dates provided). Biopsy showed some type of damage to his kidney. He was not hospitalized. Edema was continued. He had follow-up appointment with his physician on 12 Apr 2012. The final outcome of the events was reported as unknown.
Age: 11.0
Sex: F
Vaccine: MNQ, VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Right arm where varicella vaccine was given became swollen, red, warm about 12 hours after vaccination. Swelling significanty increased in size within 6 hours. Mom recalls similar reaction when child received 1st dose of varicella vaccine at 1yr of age. Area affected was thigh. Treatment required at this time included drainage of affected area and hospitalization.
Age: 44.0
Sex: F
Vaccine: TDAP
Symptoms: Asthma, Condition aggravated, Injection site erythema, Injection site swelling
Clinical narrative: Initial report was received from a health care professional on 06 April 2012. The reporter also reported two other adverse events for two other patients which were captured in case numbers 2012-03758 and 2012-03760. A 44-year-old female patient, with a medical history of asthma, seasonal allergies and anxiety attacks, had received a dose one intramuscular injection in the left deltoid of ADACEL, sanofi pasteur Ltd. lot number C3940 (sanofi pasteur Inc. lot number U4046AA) on 04 April 2012 when she had an acute asthma attack. On 06 April 2012, the patient had a site reaction of redness and swelling that was treated with ice packs, TYLENOL and BENADRYL as needed (PRN). The patient was at the doctor's office for recurring asthma attack and not for the site reaction. The patient's concomitant medications included nebulizer, SINGULAIR and PROVENTIL. The patient's outcome was not reported. Documents held by sender: None.
Age: 17.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Dizziness, Presyncope
Clinical narrative: Dizziness 2 1/2 hours after vaccine. Mom also reports what sounds like near-syncope at that time. Her symptoms lasted about 15 minutes then she returned to baseline.
Age: 28.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Blood test, Caesarean section, Maternal exposure during pregnancy, Ultrasound antenatal screen normal
Clinical narrative: Information has been received from a registered nurse for the pregnancy registry for VARIVAX (Merck) concerning a 28 year old female patient with no allergies or drug reaction history who on 06-APR-2011, was vaccinated with a dose of VARIVAX (Merck) 0.5 ml, subcutaneously (lot number 668455/1310Z, Exp. 07-OCT-2012). Secondary suspect therapy included vaccination with a dose of MMR II, 0.5 ml, subcutaneously (lot number 669017/1250Z, Exp. 28-JUN-2012). Other concomitant therapy included prenatal vitamins (unspecified). The vaccines were administered while the patient was 10 weeks pregnant, Approximated LMP: 26-JAN-2011. EDD: 02-NOV-2011. The nurse mentioned that the nurse who gave the vaccines asked the patient through the help of a "language line", if the patient was pregnant and the patient denied being pregnant. The patient sought unspecified medical attention. The patient did not receive any treatment. The nurse reported that blood work was performed (no results were provided). At the time of the report the outcome of the patient was unknown. Follow up information has been received from a registered nurse. It was reported that the patient with a history of 1 pregnancy and 1 full term delivery, no stillbirths or miscarriages was vaccinated on 06-APR-2011 with a 0.5 ml dose of VARIVAX (Merck) (lot number 668455/1310Z). The patient was not tested for varicella antibodies before vaccination with VARIVAX (Merck). The patient did not have a local reaction at vaccination site or any varicella or herpes zoster symptoms post vaccination. Follow up information has been received via pregnancy Questionnaire from a registered nurse concerning the 28 year old female patient that was pregnant. The physician reported that on 20-APR-2011, 17-AUG-2011, 01-NOV-2011 and 20-NOV-2011 an ultrasounds were performed which showed normal, normal breast size and "datas", anatomic "survey" and right position. It was reported that on 10-MAY-2011, the patient started taking prenatal vitamins. On 20-NOV-2011, 40 weeks from last menstrual period (LMP), the patient gave birth a healthy baby boy with no any feature of congenital varicella zoster syndrome. No complications were reported during pregnancy and during labor/delivery. No diagnostic tests were performed and no infections or illness were reported during pregnancy. No concurrent conditions were reported. Follow up information was received from medical records. The patient delivered a baby on 20-NOV-2011 via C-section. Upon internal review, C-section was considered to be an other important medical event. The baby's experience has been captured in WAES1104USA01360B1. Additional information has been requested. All available medical records will be provided upon request.
Age: 0.51
Sex: F
Vaccine: DTAPHEPBIP, FLU3, HIBV, PNC13, RV1
Symptoms: Pyrexia, Vaccine positive rechallenge
Clinical narrative: Fever 104 + within 12 hours of administration at 4 mo and 6 mo immunizations. Resulted in 2nd visit to clinic but no adverse outcome (see other side). Discussed risks of not immunizing greater then febrile illness controlled with antipyretics. Mother in agreement. Discussed likely exaggerated response to immunizations.
Age: 2.0
Sex: M
Vaccine: DTAPIPVHIB
Symptoms: Diarrhoea, Injection site erythema, Injection site swelling, Irritability, Vomiting
Clinical narrative: (1) Diarrhea x 3 days started 4/12/12 - > 4/15/12. (2) Vomiting 4/13/12 x 2. (3) Irritability 4/12 - 4/13/12 2 days. (4) Swelling & erythema 4/12/12 -> 3:00 pm left thigh.
Age: 11.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Purpura, Rash
Clinical narrative: 3 days after getting the HPV vaccine she developed a rash on feet, palpable purpuric. Also developed on palpable bump on breast but not purpuric.
Age: 11.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Breast mass, Palpable purpura, Rash
Clinical narrative: 3 days after getting the HPV vaccine she developed a rash on feet, palpable purpuric. Also developed on palpable bump on breast but not purpuric.
Age: 20.0
Sex: F
Vaccine: TYP
Symptoms: Dizziness, Headache, Nausea
Clinical narrative: Headache, nausea, dizziness.
Age: 71.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site mass, Injection site swelling, Pain, Vaccination complication
Clinical narrative: Pt. was administered 0.5 mL of Tdap in (L) delt on 4/06/12, pt. presents on 4/19/12 with red, erythematic, slightly elevated area over right upper arm. Area slightly raised, but on palpation a small lump appr. 1 inch x 1 inch can be felt, approximate rash is 2 1/2 inch x 4 1/2 inch and is in a circular shape around (R) upper arm. Pt. complains of moderate pain when moving arm.
Age: 3.0
Sex: M
Vaccine: VARCEL
Symptoms: Cough, Dyspnoea, Emotional distress, Feeling abnormal, Nausea
Clinical narrative: See attached printed visit note. Patient presents with difficulty breathing. It began 1/4 hours ago. It is of moderate intensity. The typical duration of an episode is 10-15 min, after receiving VARIVAX. Associated symptoms include cough, nausea and pallor. Was in office for 2nd VARIVAX today per Dept of Health because his brother was Dx with chickenpox. No reported reaction to first VARIVAX. Received VARIVAX, seemed fine. After 5 min or so, left office. As exiting the building, he told mom he "did not feel good", seemed pale. The c/o difficulty breathing. Mom brought him right back to office. He appeared in distress, and was quickly put in a room and assessment began by RN.
Age: 3.0
Sex: M
Vaccine: VARCEL
Symptoms: Pallor
Clinical narrative: See attached printed visit note. Patient presents with difficulty breathing. It began 1/4 hours ago. It is of moderate intensity. The typical duration of an episode is 10-15 min, after receiving VARIVAX. Associated symptoms include cough, nausea and pallor. Was in office for 2nd VARIVAX today per Dept of Health because his brother was Dx with chickenpox. No reported reaction to first VARIVAX. Received VARIVAX, seemed fine. After 5 min or so, left office. As exiting the building, he told mom he "did not feel good", seemed pale. The c/o difficulty breathing. Mom brought him right back to office. He appeared in distress, and was quickly put in a room and assessment began by RN.
Age: 63.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Chills, Drug eruption, Injection site erythema, Injection site pain, Injection site pruritus
Clinical narrative: Local title: Physician assistant ER note. Date of note: OCT 16, 2010 at 19:03 chief complaint: rash. Present Illness: This is a 63yo, male, came to ER with: receiving PNEUMOVAX 2 days ago, developed redness in the area, some soreness, little pruritus. Some chills the night of the immunization, none since. Allergies: lamotrigine, DEPAKOTE, fluvastatin, BAYCOL, lovastatin, atorvastatin, trazodone. Review of system: Cardiovascular: None, no chest pain. Pulmonary: None, no SOB.  Neurological: No H/O arthritis. Physical exam: Temp: 98 F [36.7 C], (10/16/2010 18:53). BP: 160/102 (10/16/2010 18:53), Resp: 16 (10/16/2010 18:53), Pulse: 97 (10/16/2010 18:53), Pain 2 (10/16/2010 18:53). General: ambulatory, awake, alert, Skin: lateral right bicep, there is confluent erythema, slightly raised, NT, no scale. Warm to palpation. Assessment: 1) local drug rash. Plan: 1) cool compresses, 2) BENADRYL 25 mg tid, 3) if fever, chills, sweats, return to ER.
Age: 63.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Injection site swelling, Rash, Skin warm
Clinical narrative: Local title: Physician assistant ER note. Date of note: OCT 16, 2010 at 19:03 chief complaint: rash. Present Illness: This is a 63yo, male, came to ER with: receiving PNEUMOVAX 2 days ago, developed redness in the area, some soreness, little pruritus. Some chills the night of the immunization, none since. Allergies: lamotrigine, DEPAKOTE, fluvastatin, BAYCOL, lovastatin, atorvastatin, trazodone. Review of system: Cardiovascular: None, no chest pain. Pulmonary: None, no SOB.  Neurological: No H/O arthritis. Physical exam: Temp: 98 F [36.7 C], (10/16/2010 18:53). BP: 160/102 (10/16/2010 18:53), Resp: 16 (10/16/2010 18:53), Pulse: 97 (10/16/2010 18:53), Pain 2 (10/16/2010 18:53). General: ambulatory, awake, alert, Skin: lateral right bicep, there is confluent erythema, slightly raised, NT, no scale. Warm to palpation. Assessment: 1) local drug rash. Plan: 1) cool compresses, 2) BENADRYL 25 mg tid, 3) if fever, chills, sweats, return to ER.
Age: 46.0
Sex: M
Vaccine: PPV
Symptoms: Body temperature increased, Injection site induration, Myalgia, Nasal congestion, Nausea
Clinical narrative: Patient temperature increased from midnight until this time. 100.8 increased to 102.5. TYLENOL no effective. Pt. reports body aches. ZOFRAN effective for nausea. 01/27/2012 ADDENDUM STATUS: COMPLETED. Received a call at 1.45 am from nursing staff need a TYLENOL order and temp was 102. No focal signs was from vaccination had during day time plan: ordered TYLENOL 650mg now order. Vitals q2 hrs. Symptoms: Myalgia, Fever & Stuffy nose, injection site induration. Treatment: Acetaminophen 650 mg PRN, Ibuprofen 400 mg PRN, Ondansetron 4 mg PRN.
Age: 46.0
Sex: M
Vaccine: PPV
Symptoms: Pain, Pyrexia
Clinical narrative: Patient temperature increased from midnight until this time. 100.8 increased to 102.5. TYLENOL no effective. Pt. reports body aches. ZOFRAN effective for nausea. 01/27/2012 ADDENDUM STATUS: COMPLETED. Received a call at 1.45 am from nursing staff need a TYLENOL order and temp was 102. No focal signs was from vaccination had during day time plan: ordered TYLENOL 650mg now order. Vitals q2 hrs. Symptoms: Myalgia, Fever & Stuffy nose, injection site induration. Treatment: Acetaminophen 650 mg PRN, Ibuprofen 400 mg PRN, Ondansetron 4 mg PRN.
Age: 11.0
Sex: M
Vaccine: HPVX
Symptoms: Injection site erythema, Injection site pain, Injection site urticaria, Injection site warmth
Clinical narrative: Pt developed a lg. about 4 in red wheal to (L) deltoid region with (+) tenderness & warmth to site.
Age: 0.37
Sex: M
Vaccine: DTAPIPVHIB
Symptoms: Incorrect dose administered
Clinical narrative: No Dup HIB vaccination.
Age: 66.0
Sex: M
Vaccine: VARZOS
Symptoms: Headache, Tension
Clinical narrative: Pt reports tension in upper back and neck with a mild headache beginning the day after vaccination administration. No treatment used.
Age: 32.0
Sex: F
Vaccine: TDAP
Symptoms: Fatigue, Injection site erythema, Nausea, Pyrexia
Clinical narrative: Redness around shot site began to expand and spread 3 inches in diameter around and patient required antibiotics, fever 100.4, nausea, fatigue.
Age: 3.0
Sex: M
Vaccine: PNC13
Symptoms: Erythema, Skin warm, Swelling
Clinical narrative: Area red, hot and swollen. No treatment needed, instructed parent to watch for SOB and progression, if any, of area getting worse, to report back to the clinic.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain in extremity, Skin warm, Tenderness
Clinical narrative: Left arm very painful for over 1 week.  Tender.  No rash. Mild warmth.
Age: 22.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Arthralgia, Body temperature increased, Chills, Diarrhoea, Heart rate increased
Clinical narrative: Temp 102-103 x 3-4 hrs, joint pain, muscle aches, chills, rapid heart rate, nausea/vomiting/diarrhea s/s lasted 3-4 hrs.
Age: 22.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Myalgia, Nausea, Vomiting
Clinical narrative: Temp 102-103 x 3-4 hrs, joint pain, muscle aches, chills, rapid heart rate, nausea/vomiting/diarrhea s/s lasted 3-4 hrs.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site hypersensitivity, Injection site swelling, Injection site urticaria, Injection site warmth
Clinical narrative: 6-7" circle of swollen, red, sensitive flesh w/1"x2" very hot, red, swollen center area at injection site. Almost looks like hives, but is larger and limited to injection site.
Age: 47.0
Sex: F
Vaccine: FLUX
Symptoms: Injection site pain, Musculoskeletal pain, Nuclear magnetic resonance imaging normal, Pain in extremity, Tendonitis
Clinical narrative: Sore arm.
Age: 47.0
Sex: F
Vaccine: FLUX
Symptoms: X-ray limb abnormal
Clinical narrative: Sore arm.
Age: 30.0
Sex: M
Vaccine: TDAP
Symptoms: Urticaria
Clinical narrative: Pt broke out in large hives neck/trunk approx. 2hrs following Tdap injection. Denies difficulty breathing. Per v.o. Dr., pt to take oral Bendaryl, prednisone, and seek immediate medical attention should symptoms progress.
Age: 1.01
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Abasia, Cough, Dizziness, Dyskinesia, Posture abnormal
Clinical narrative: Mom reported "that night after shots at about 6 pm, he developed a severe cough, which made him vomit; his sister also had this same cough and she did not get any shots." the kids were seen by a doctor for this cough on 4/18/12 and md order Mucinex. Mom gave a dose after returning home. First dose at about 3:30 pm. Then about 45 minutes after the first dose of Mucinex, "he could not walk, sit up, his head turned sharply to the left, he toppled over and was lying on the floor, his body was very straight and he was screaming the whole time, his head remained turned to the left, and his body was jerking against me when I held him." "After this, he seem dizzy and could not walk for about 25 minutes, I called the pediatrician and she told me to call poison control and to not give anymore Mucinex, poison control said they have never heard of this type of reaction to Mucinex." "He went to bed early and slept, we have had no further symptoms, except the cough is still there, I am taking him back to the pediatrician now".